ArticleCureus2024
Evaluating the Perceived Benefits and Effectiveness of a Government Health Insurance Scheme for Chronic Kidney Disease Patients: A Study in Nellore, Andhra Pradesh.
Article in Cureus, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background Chronic kidney disease (CKD) is prevalent in India, particularly among underprivileged populations. Government initiatives such as the Dr. YSR Aarogyasri Health Insurance Scheme aim to provide affordable healthcare to economically impoverished individuals with kidney diseases. This study assessed participants' perceptions of the scheme's benefits, effectiveness, and challenges. Methods A cross-sectional study was conducted in Nellore, Andhra Pradesh, involving 100 CKD patients. Data was collected using a structured questionnaire assessing socio-demographic factors, insurance scheme's awareness, perceived benefits, and effectiveness. Multivariable logistic regression analysis was employed to identify factors influencing participants' perceptions. Results Participants aged over 40 years were more likely to perceive the Dr. YSR Aarogyasri Health Insurance Scheme positively (crude odds ratio {COR}: 9.2; 95% CI: 2.6-31.7). Males (adjusted odds ration {aOR} 1.5; 95% CI: 1.1-2.1), married individuals (aOR 1.3; 95% CI: 0.8-1.7), and those with higher education (aOR 1.9; 95% CI: 1.1-3.2) reported greater scheme effectiveness. However, 32% of CKD patients lacked awareness of the scheme's enrolment process, 29% believed that the eligibility criteria were too strict, and 17% of insured patients reported gaps in coverage for specific services, treatments, and medications, reducing the scheme's appeal to diseased patients. Discussion Older males and those with diabetes, who require extensive care, perceive the scheme as beneficial. However, gaps in awareness and coverage remain barriers to its full effectiveness. Conclusion While the Dr. YSR Aarogyasri Health Insurance Scheme provides critical financial relief for CKD patients, enhancing its outreach and expanding coverage could improve its impact. These findings can guide policy improvements to optimize the scheme's effectiveness and accessibility.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.